VACC Overview

Key Data

  • Open $14.45
  • Day Range 14.20 - 14.74
  • 52 Week Range 12.25 - 17.99
  • Market Cap $368.91K
  • Shares Outstanding 34.06M
  • Public Float N/A
  • Beta 0.48
  • Rev. per Employee N/A
  • P/E Ratio N/A
  • EPS N/A
  • Yield N/A
  • Dividend N/A
  • Ex-Dividend Date N/A
  • Short Interest 0 04/30/21
  • % of Float Shorted N/A
  • Average Volume 170.19K

Performance

5 Day
  • -15.96%

Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4 Full Ratings

Recent News

  • MarketWatch
  • Dow Jones

Vaccitech started at overweight at Morgan Stanley

May. 25, 2021 at 12:08 p.m. ET by Tomi Kilgore
Barron's

Oatly, Procore Technologies IPOs See Big Gains

May. 20, 2021 at 11:44 a.m. ET by Barron's
Barron's

Oatly Is Going Public Today. What Investors Need to Know.

May. 19, 2021 at 5:54 p.m. ET
Barron's

Valneva Gains in Nasdaq Debut as Rival Vaccine Makers Fall

May. 6, 2021 at 1:03 p.m. ET by Barron's
  • Other News
  • Press Releases

H.C. Wainwright Initiates a Buy Rating on Vaccitech Plc Sponsored ADR (VACC)

May. 24, 2021 at 6:19 a.m. ET on SmarterAnalyst

VACC Stock IPO: 7 Things to Know as Vaccitech Starts Trading Today

Apr. 30, 2021 at 1:53 p.m. ET on InvestorPlace.com

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

Apr. 28, 2021 at 5:58 p.m. ET on InvestorPlace.com

Vaccitech IPO: When Does Vaccitech Go Public? What Is the VACC Stock IPO Price Range?

Apr. 28, 2021 at 2:46 p.m. ET on InvestorPlace.com

Vaccitech PLC ADR

Vaccitech Plc operates as a holding company. It is engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company was founded in March 2021 and is headquartered in Oxford, the United Kingdom.